참고문헌
- Kim IH, Chie EK, Oh DH, et al. A web-based "patterns of care study" system for clinical radiation oncology in Korea: development, launching, and characteristics. J Korean Soc Ther Radiat Oncol 2003;21:291-8.
- Kim JH, Kim DY, Kim YH, et al. Survey on radiotherapy protocols for the rectal cancers among the Korean radiation oncologists in 2002 for the development of the patterns of care study of radiation therapy. J Korean Soc Ther Radiol Oncol 2003;21:44-53.
- Hur WJ, Choi Y, Lee HS, et al. Preliminary report of the 1998-1999 patterns of care study of radiation therapy for esophageal cancer in Korea. J Korean Soc Ther Radiol Oncol 2007;25:79-92.
- Suh CO, Shin HS, Cho JH, et al. The 1998, 1999 patterns of care study for breast irradiation after breast-conserving surgery in Korea. J Korean Soc Ther Radiol Oncol 2004;22:192-9.
- Keum KC, Shim SJ, Lee IJ, et al. The 1998, 1999 patterns of care study for breast irradiation after mastectomy in Korea. J Korean Soc Ther Radiol Oncol 2007;25:7-15.
- Kim JH, Kim JS, Ha SW, et al. A patterns of care study of the various radiation therapies for prostate cancer among Korean radiation oncologists in 2006. J Korean Soc Ther Radiol Oncol 2008;26:96-103. https://doi.org/10.3857/JKSTRO.2008.26.2.96
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29. https://doi.org/10.3322/caac.21208
- Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127-41. https://doi.org/10.4143/crt.2015.060
- Wang D, Ho A, Hamilton AS, et al. Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer. Radiat Oncol 2014;9:47. https://doi.org/10.1186/1748-717X-9-47
- Aneja S, Smith BD, Gross CP, et al. Geographic analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys 2012;82:1723-9. https://doi.org/10.1016/j.ijrobp.2011.01.070
- Mahmood U, Levy LB, Nguyen PL, Lee AK, Kuban DA, Hoffman KE. Current clinical presentation and treatment of localized prostate cancer in the United States. J Urol 2014;192:1650-6. https://doi.org/10.1016/j.juro.2014.06.017
- Park J, Suh B, Shin DW, Hong JH, Ahn H. Changing patterns of primary treatment in Korean men with prostate cancer over 10 years: a nationwide population based study. Cancer Res Treat 2016;48:899-906. https://doi.org/10.4143/crt.2015.212
- Wang-Chesebro A, Xia P, Coleman J, Akazawa C, Roach M 3rd. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with threedimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2006;66:654-62. https://doi.org/10.1016/j.ijrobp.2006.05.037
- Beckendorf V, Guerif S, Le Prise E, et al. 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial. Int J Radiat Oncol Biol Phys 2011;80:1056-63. https://doi.org/10.1016/j.ijrobp.2010.03.049
- Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005;294:1233-9. https://doi.org/10.1001/jama.294.10.1233
- Lawton CA, DeSilvio M, Roach M 3rd, et al. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys 2007;69:646-55. https://doi.org/10.1016/j.ijrobp.2007.04.003
- Pommier P, Chabaud S, Lagrange JL, et al. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01. J Clin Oncol 2007;25:5366-73. https://doi.org/10.1200/JCO.2006.10.5171
- Bolla M, van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTC trial 22911). Lancet 2005;366:572-8. https://doi.org/10.1016/S0140-6736(05)67101-2
- Denham JW, Joseph D, Lamb DS, et al. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial. Lancet Oncol 2014;15:1076-89. https://doi.org/10.1016/S1470-2045(14)70328-6
- Pilepich MV, Winter K, John MJ, et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001;50:1243-52. https://doi.org/10.1016/S0360-3016(01)01579-6
- Denham JW, Steigler A, Lamb DS, et al. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncol 2005;6:841-50. https://doi.org/10.1016/S1470-2045(05)70348-X
- Bolla M, de Reijke TM, Van Tienhoven G, et al. Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med 2009;360:2516-27. https://doi.org/10.1056/NEJMoa0810095
- Horwitz EM, Bae K, Hanks GE, et al. Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. J Clin Oncol 2008;26:2497-504. https://doi.org/10.1200/JCO.2007.14.9021
- Denham JW, Steigler A, Lamb DS, et al. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. Lancet Oncol 2011;12:451-9. https://doi.org/10.1016/S1470-2045(11)70063-8
피인용 문헌
- Optimal collimator rotation based on the outline of multiple brain targets in VMAT vol.13, pp.None, 2017, https://doi.org/10.1186/s13014-018-1039-5
- The Treatments for Intermediate Risk Prostate Cancer vol.17, pp.1, 2017, https://doi.org/10.22465/kjuo.2019.17.1.22
- Elective pelvic irradiation in prostate cancer patients with biochemical failure following radical prostatectomy: A propensity score matching analysis vol.14, pp.4, 2017, https://doi.org/10.1371/journal.pone.0215057
- Prognostic significance of lymphovascular invasion in patients with prostate cancer treated with postoperative radiotherapy vol.37, pp.3, 2017, https://doi.org/10.3857/roj.2019.00332